{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:13:16Z","timestamp":1786738396409,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.dld.2013.10.012","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T17:12:19Z","timestamp":1385053939000},"page":"283-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer"],"prefix":"10.1016","volume":"46","author":[{"given":"Yann","family":"Touchefeu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Archambeaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Li\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Lep\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 8","key":"10.1016\/j.dld.2013.10.012_bib0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0959-8049(01)00267-2","article-title":"Cancer burden in the year 2000. The global picture","volume":"37","author":"Parkin","year":"2001","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.dld.2013.10.012_bib0010","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0959-8049(98)00329-3","article-title":"Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group","volume":"34","author":"Faivre","year":"1998","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.dld.2013.10.012_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1096-9098(200012)75:4<227::AID-JSO1>3.0.CO;2-2","article-title":"Is esophageal cancer a surgical disease?","volume":"75","author":"Harrison","year":"2000","journal-title":"Journal of Surgical Oncology"},{"key":"10.1016\/j.dld.2013.10.012_bib0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.gie.2006.04.040","article-title":"Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas","volume":"65","author":"Ross","year":"2007","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1016\/j.dld.2013.10.012_bib0025","doi-asserted-by":"crossref","DOI":"10.3310\/hta9050","article-title":"A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer","volume":"9","author":"Shenfine","year":"2005","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.dld.2013.10.012_bib0030","first-page":"316","article-title":"A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus","volume":"6","author":"Ilson","year":"2000","journal-title":"Cancer Journal"},{"key":"10.1016\/j.dld.2013.10.012_bib0035","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.1999.17.10.3270","article-title":"Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer","volume":"17","author":"Ilson","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2013.10.012_bib0040","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/014107687907201206","article-title":"Management of malignant dysphagia by intubation at endoscopy","volume":"72","author":"Atkinson","year":"1979","journal-title":"Journal of the Royal Society of Medicine"},{"key":"10.1016\/j.dld.2013.10.012_bib0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/annonc\/mdh182","article-title":"Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma","volume":"15","author":"Mitry","year":"2004","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2013.10.012_bib0050","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2013.10.012_bib0055","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2013.10.012_bib0060","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0959-8049(01)00400-2","article-title":"Optimisation of 5-fluorouracil (5-FU)\/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer","volume":"38","author":"Taieb","year":"2002","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.dld.2013.10.012_bib0065","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2013.10.012_bib0070","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.3747\/co.19.892","article-title":"What is the optimal management of dysphagia in metastatic esophageal cancer?","volume":"19","author":"Hanna","year":"2012","journal-title":"Current Oncology"},{"key":"10.1016\/j.dld.2013.10.012_bib0075","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1111\/j.1572-0241.2007.01565.x","article-title":"A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia","volume":"102","author":"Conio","year":"2007","journal-title":"American Journal of Gastroenterology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865813006269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865813006269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T01:02:13Z","timestamp":1647478933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865813006269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1590865813006269"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2013.10.012","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2013.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}